Better pain medications, known as Nav1.8 inhibitors, could be the first new drugs in decades for chronic pain conditions that don't respond to existing.
4 weeks ago

Virpax Pharmaceuticals advances development of NES100, a breakthrough nasal spray using nanotechnology to deliver pain relief without opioid-related side...
2 weeks ago

Researchers have developed a non-addictive painkiller that remains inactive until it reaches sites of chronic pain. Instead of dulling the nerves that send...
3 weeks ago

Ijeoma Uchegbu discusses nanomedicine's role in improving medication adherence and developing non-addictive pain relief solutions at ELRIG Drug Discovery...
2 weeks ago

By Pat Anson. Are doctors and pharmacists helping the DEA spy on pain patients? Does Big Pharma control how healthcare news is reported?
1 week ago

Neural Ice: Is this long-lasting pain therapy revolutionizing treatment?
2 weeks ago

The nation's three largest drug distributors – McKesson Corp, Cardinal Health Inc, and Cencora Inc – recently agreed to pay $300 million to health plans to...
3 weeks ago

A team of international researchers including those from the University of Adelaide have taken a well-known chemical reaction as the basis of a new...
3 weeks ago

On Oct. 1, University of Connecticut Health Center professors Lakshmi Nair and Yusuf Khan were awarded first place at the Wolff New Venture Competition for...
4 weeks ago

PRNewswire/ -- CureLab Oncology, a clinical-stage biotech company dedicated to pioneering innovative therapies, announced a patent application for an...
3 weeks ago